Nexalin Technology Inc.

30/07/2024 | Press release | Distributed by Public on 31/07/2024 04:30

Management Change/Compensation Form 8 K

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On July 29, 2024, Michael Nketiah submitted his resignation as the Senior Vice President of Clinical, Quality, & Regulatory Affairs of Nexalin Technology Inc. (the "Company"). Mr. Nketiah's resignation will be effective on August 16, 2024. He will continue to serve the Company as its Senior Vice President of Clinical, Quality, & Regulatory Affairs until such effective date.

Mr. Nketiah advised that he is departing the Company to pursue another professional opportunity. Mr. Nketiah's resignation is not the result of any disagreement with the Company.